Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies
Abstract The tumor suppressor p53, often referred to as the “guardian of the genome,” is mutated in more than half of human cancers. These mutations have a significant impact on cancer biology and response to therapy. p53 mutations involve a range of changes that interfere with DNA binding, eliminat...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
BMC
2026-03-01
|
| Цуврал: | Cellular & Molecular Biology Letters |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://doi.org/10.1186/s11658-026-00907-x |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|